The immunological monitoring of kidney and liver transplants in adult and pediatric recipients

Transplant Immunology

Volumn 22, Issue 1-2, 2009, Pages 18-27

  Truong, Dinh Quang ^a,b   Bourdeaux, Christophe ^a   Wieërs, Grégoire ^a   Saussoy, Pascale ^a   Latinne, Dominique ^a   Reding, Raymond ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b University Medical Center   (Viet Nam)

Author keywords

Immunological monitoring; Pediatric transplantation; Rejection; Tolerance

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD30 LIGAND; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 13; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; TETRAMER; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHIMERA; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HIGH RISK PATIENT; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MONITORING; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MICROARRAY ANALYSIS; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PROTEOMICS; REGULATORY T LYMPHOCYTE; REVIEW; TRANSPLANTATION TOLERANCE;

ADULT; CHILD; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MONITORING, IMMUNOLOGIC;

EID: 70449529764     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.09.008     Document Type: Review

References (83)

1. Evrard V., Otte J.B., Sokal E., Rochet J.S., Haccourt F., Gennari F., et al. Impact of surgical and immunological parameters in pediatric liver transplantation: a multivariate analysis in 500 consecutive recipients of primary grafts. Ann Surg 239 (2004) 272-280
2. Bourdeaux C., Darwish A., Jamart J., Tri T.T., Janssen M., Lerut J., et al. Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. Am J Transplant 7 (2007) 440-447
3. Gras J.M., Gerkens S., Beguin C., Janssen M., Smets F., Otte J.B., et al. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children. Liver Transpl 14 (2008) 469-477
4. Fernando O.N. Dilemmas in pediatric renal transplantation. Trans Proc 38 (2006) 1992-1994
5. Ashton-Chess J., Giral M., Soulillou J.P., and Brouard S. Can immune monitoring help to minimize immunosuppression in kidney transplantation?. Transpl Int 22 (2009) 110-119
6. Benichou G., Valujskikh A., and Heeger P.S. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 162 (1999) 352-358
7. Golshayan D., Buhler L., Lechler R.I., and Pascual M. From current immunosuppressive strategies to clinical tolerance of allografts. Transpl Int 20 (2007) 12-24
8. Ekong U.D., Miller S.D., and O'Gorman M.R. In vitro assays of allosensitization. Pediatr Transplant 13 (2009) 25-34
9. Koshiba T., Li Y., Takemura M., Wu Y., Sakaguchi S., Minato N., et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 17 (2007) 94-97
10. Segall M., Noreen H., Edwins L., Haake R., Shu X.O., and Kersey J. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. Hum Immunol 49 (1996) 49-55
11. Hernandez-Fuentes M.P., Warrens A.N., and Lechler R.I. Immunologic monitoring. Immunol Rev 196 (2003) 247-264
12. Chung S.W., Yoshida E.M., Cattral M.S., Hu Y., and Gorczynski R.M. Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett 63 (1998) 91-96
13. Chen Y., and Wood K.J. Interleukin-23 and TH17 cells in transplantation immunity: does 23 + 17 equal rejection?. Transplantation 84 (2007) 1071-1074
14. Warlé M.C., Farhan A., Metselaar H.J., Hop W.C., van der Plas A.J., Kap M., et al. In vitro cytokine production of TNFalpha and IL-13 correlates with acute liver transplant rejection. Hum Immunol 62 (2001) 1258-1265
15. Saleem S., Konieczny B.T., Lowry R.P., Baddoura F.K., and Lakkis F.G. Acute rejection of vascularized heart allografts in the absence of IFN gamma. Transplantation 62 (1996) 1908-1911
16. Nickerson P., Zheng X.X., Steiger J., Steele A.W., Steurer W., Roy-Chaudhury P., et al. Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transpl Immunol 4 (1996) 81-85
17. Weimar W., Rischen-Vos J., de Kuiper P., Gregoor P.J., IJzermans J.N., van Besouw N.M., et al. Tapering immunosuppression in recipients of living donor kidney transplants. Nephrol Dial Transplant 19 (2004) 61-63 suppl
18. Najafian N., Albin M.J., and Newell K.A. How can we measure immunologic tolerance in humans?. J Am Soc Nephrol 17 (2006) 2652-2663
19. Kwok W.W. Challenges in staining T cells using HLA class II tetramers. Clin Immunol 106 (2003) 23-28
20. Suchin E.J., Langmuir P.B., Palmer E., Sayegh M.H., Wells A.D., and Turka L.A. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 166 (2001) 973-981
21. Tanaka Y., Ohdan H., Onoe T., Mitsuta H., Tashiro H., and Itamoto T.A.T. Low incidence of acute rejection after living-donor liver transplantation: immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 79 (2005) 1262-1267
22. Newell K.A., and Larsen C.P. Tolerance assays: measuring the unknown. Transplantation 81 (2006) 1503-1509
23. van Besouw N.M., Zuijderwijk J.M., de Kuiper P., Ijzermans J.N., Weimar W., and van der Mast B.J. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 79 (2005) 1062-1066
24. Augustine J.J., Siu D.S., Clemente M.J., Schulak J.A., Heeger P.S., and Hricik D.E. Pre-transplant IFN-gamma ELISPOT are associated with post-transplant renal function in African American renal transplant recipients. Am J Transplant 5 (2005) 1971-1975
25. Nickel P., Presber F., Bold G., Biti D., Schönemann C., Tullius S.G., et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 78 (2004) 1640-1646
26. Näther B.J., Nickel P., Bold G., Presber F., Schönemann C., Pratschke J., et al. Modified ELISPOT technique-highly significant inverse correlation of post-Tx donor-reactive IFN-gamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Transpl Immunol 16 (2006) 232-237
27. Najafian N., Salama A.D., Fedoseyeva E.V., Benichou G., and Sayegh M.H. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13 (2002) 252-259
28. Truong D.Q., Cornet A., Wieërs G., Robert A., Reding R., and Latinne D. Pre- and post-transplant monitoring of granzyme B enzyme-linked immunosorbent spot assay in pediatric liver recipients. Transpl Immunol 19 (2008) 215-219
29. Pelletier R.P., Hennessy P.K., Adams P.W., and Orosz C.G. High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. Am J Transplant 2 (2002) 926-933
30. VanBuskirk A.M., Burlingham W.J., Jankowska-Gan E., Chin T., Kusaka S., Geissler F., et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 106 (2000) 145-155
31. Pelletier R.P., Bickerstaff A.A., Adams P.W., and Orosz C.G. Evaluation of immune regulation in transplant patients using the trans-vivo delayed type hypersensitivity assay. Hum Immunol 68 (2007) 514-522
32. Altermann W.W., Seliger B., Sel S., Wendt D., and Schlaf G. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure. Histol Histopathol 21 (2006) 1115-1124
33. Billen E.V., Voorter C.E., Christiaans M.H., and van den Berg-Loonen E.M. Luminex donor-specific crossmatches. Tissue Antigens 71 (2008) 507-513
34. Zhang Q., Liang L.W., Gjertson D.W., Lassman C., Wilkinson A.H., Kendrick E., et al. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation 79 (2005) 591-598
35. Rifle G., Mousson C., Martin L., Guignier F., and Hajji K. Donor-specific antibodies in allograft rejection: clinical and experimental data. Transplantation 79 (2005) S14-S18
36. Wright E.J., Fiser W.P., Edens R.E., Frazier E.A., Morrow W.R., Imamura M., et al. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch. J Heart Lung Transplant 26 (2007) 1163-1169
37. Fehr T., and Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int 21 (2008) 1118-1135
38. Kingsley C.I., Nadig S.N., and Wood K.J. Transplantation tolerance: lessons from experimental rodent models. Transpl Int 20 (2007) 828-841
39. Bettens F., Tiercy J.M., Campanile N., Giostra E., Majno P., and Rubbia L. Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivity. Liver Transpl 11 (2005) 290-297
40. Alexander S.I., Smith N., Hu M., Verran D., Shun A., Dorney S., Shaw P.J.L.A., Stormon M.O., et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 358 (2008) 369-374
41. Fudaba Y., Spitzer T.R., Shaffer J., Kawai T., Fehr T., Delmonico F., et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 6 (2006) 2121-2133
42. Scandling J.D., Busque S., Dejbakhsh-Jones S., Benike C., Millan M.T., Shizuru J.A., et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 358 (2008) 362-368
43. Reding R., Gras J., Truong D.Q., Wieërs G., and Latinne D. The immunological monitoring of alloreactive responses in liver transplant recipients: a review. Liver Transpl 12 (2006) 373-383
44. Gras J., Wieërs G., Vaerman J.L., Truong D.Q., Sokal E., Otte J.B., et al. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients. Liver Transpl 13 (2007) 426-433
45. Susal C., Pelzl S., Simon T., and Opelz G. Advances in pre-and posttransplant immunologic testing in kidney transplantation. Trans Proc 36 (2004) 29-34
46. Pellegrini P., Berghella A.M., Contasta I., and Adorno D. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Transpl Immunol 12 (2003) 49-61
47. Cinti P., Pretagostini R., Arpino A., Tamburro M.L., Mengasini S., Lattanzi R., et al. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. Transplantation 79 (2005) 1154-1156
48. Susal C., Pelzl S., Dohler B., and Opelz G. Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol (2002) 1650-1656
49. Rajakariar R., Jivanji N., Varagunam M., Rafiq M., Gupta A., Sheaff M., et al. High pre-transplant soluble CD30 levels are predictive of the grade of rejection. Am J Transplant 2 (2005) 1922-1925
50. Slavcev A., Lacha J., Honsova E., Sajdlova H., Lodererova A., Vitko S., et al. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol 14 (2005) 117-121
51. Truong D.Q., Darwish A.A., Gras J., Wieërs G., Cornet A., Robert A., de Ville de Goyet J., Reding R., Latinne D., et al. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement. Transpl Immunol 17 (2007) 283-287
52. Baron U.F.S., Wieczorek G., Baumann K., Grützkau A., Dong J., Thiel A., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 37 (2007) 2378-2389
53. Stockis J., Fink W., François V., Connerotte T., de Smet C., Knoops L., et al. Comparison of stable human Treg and Th clones by transcriptional profiling. Eur J Immunol 39 (2009) 869-882
54. Demirkiran A., Bosma B.M., Kok A., et al. Allosuppressive donor CD4 + CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation. J Immunol 178 (2007) 6066-6072
55. Chauhan S.K., Saban D.R., Lee H.K., and Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol 182 (2009) 148-153
56. Stenard F., Nguyen C., Cox K., Kambham N., Umetsu D.T., Krams S.M., et al. Decreases in circulating CD4 + CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 13 (2009) 70-80
57. Veronese F., Rotman S., Smith R.N., et al. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 7 (2007) 914-922
58. Li Y., Zhao X., Cheng D., Haga H., Tsuruyama T., Wood K., et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 86 (2008) 1837-1843
59. Hooper E., Hawkins D.M., Kowalski R.J., Post D.R., Britz J.A., Brooks K.C., et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 19 (2005) 834-839
60. Israeli M., Klein T., Sredni B., Avitzur Y., Mor E., Bar-Nathen N., et al. ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl 14 (2008) 893-898
61. Alvarez C.M., Opelz G., Giraldo M.C., Pelzl S., Renner F., Weimer R., et al. Evaluation of T-cell receptor repertoires in patients with long-term renal allograft survival. Am J Transplant 5 (2005) 746-756
62. Brouard S., Dupont A., Giral M., Louis S., Lair D., Braudeau C., et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 5 (2005) 330-340
63. Chen X., Barfield R., Benaim E., Leung W., Knowles J., Lawrence D., et al. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 105 (2005) 886-893
64. Sigdel T.K., and Sarwal M.M. The proteogenomic path towards biomarker discovery. Pediatr Transplant 12 (2008) 737-747
65. Schaub S., Wilkins J.A., and Nickerson P. Proteomics and renal transplantation: searching for novel biomarkers and therapeutic targets. Contrib Nephrol 160 (2008) 65-75
66. Quintana L.F., Solé-Gonzalez A., Kalko S.G., Bañon-Maneus E., Solé M., Diekmann F., et al. Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol 20 (2009) 428-435
67. Fujii H., Cuvelier G., She K., Aslanian S., Shimizu H., Kariminia A., et al. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood 111 (2008) 3276-3285
68. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
69. Mazariegos G.V., Zahorchak A.F., Reyes J., Ostrowski L., Flynn B., Zeevi A., et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3 (2003) 689-696
70. Mazariegos G.V., Zahorchak A.F., Reyes J., Chapman H., Zeevi A., and Thomson A.W. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 5 (2005) 314-322
71. Mazariegos G.V., Sindhi R., Thomson A.W., and Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol 17 (2007) 114-119
72. Akalin E., and Murphy B. Gene polymorphisms and transplantation. Curr Opin Immunol 13 (2001) 572-576
73. Mytilineos J., Laux G., and Opelz G. Relevance of IL10, TGFbeta1, TNFalpha, and IL4Ralpha gene polymorphisms in kidney transplantation: a collaborative transplant study report. Am J Transplant 4 (2004) 1684-1690
74. Slavcheva E., Albanis E., Jiao Q., Tran H., Bodian C., Knight R., et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation 72 (2001) 935-940
75. Mazariegos G.V., Reyes J., Webber S.A., Thomson A.W., Ostrowski L., Abmed M., et al. Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation 73 (2002) 1342-1345
76. Mendoza-Carrera F., Ojeda-Durán S., Angulo E., Rivas F., Macías-López G., Buen E.P., et al. Influence of cytokine and intercellular adhesion molecule-1 gene polymorphisms on acute rejection in pediatric renal transplantation. Pediatr Transplant 12 (2008) 755-761
77. Warlé M.C., Farhan A., Metselaar H.J., Hop W.C., Perrey C., Zondervan P.E., et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles?. Liver Transpl 9 (2003) 170-181
78. Cookson S., Doherty D.G., Todryk S., et al. Hepatic expression of IL-15mRNA is associated with liver graft acceptance. Transpl Immunol 11 (2003) 39-48
79. Fischer-Maas L., Schneppenheim R., Oyen F., Grabhorn E., Richter A., Fischer L., et al. Analysis of the CC chemokine receptor 5Delta32 polymorphism in pediatric liver transplant recipients. Pediatr Transplant 12 (2008) 769-772
80. Alakulppi N., Seikku P., Jaatinen T., Holmberg C., and Laine J. Feasibility of diagnosing subclinical renal allograft rejection in children by whole blood gene expression analysis. Transplantation 86 (2008) 1222-1228
81. Martínez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 118 (2008) 2845-2857
82. Allanach K., Mengel M., Einecke G., Sis B., Hidalgo L.G., Mueller T., et al. Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges. Am J Transplant 8 (2008) 1006-1015
83. Oei F.B., Welters M.J., Knoop C.J., Vaessen L.M., Stegmann A.P., Weimar W., et al. Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients. Eur J Cardiothorac Surg 18 (2000) 466-472